Dr. Naot is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
109 Bee St
Charleston, SC 29401
Education & Training
- New York Downtown HospitalResidency, Internal Medicine, 1996 - 1999
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1996
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1995
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1994
- The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1987
Certifications & Licensure
- FL State Medical License 2005 - 2025
- DC State Medical License 2001 - 2008
- NY State Medical License 2001 - 2007
- MD State Medical License 2001 - 2003
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 17 citationsA phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced ...Denise A. Yardley, John D. Zubkus, Brooke R. Daniel, Roger Inhorn, Cassie M. Lane
Clinical Breast Cancer. 2010-10-01 - 38 citationsPaclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary SiteJohn D. Hainsworth, David R. Spigel, Dana S. Thompson, Patrick B. Murphy, Cassie M. Lane
The Oncologist. 2009-12-01 - 27 citationsHEMATOPOIETIC PROGENITOR CELL ABNORMALITIES IN HOXC-8 NULL MUTANT MICETakashi Shimamoto, Yang Tang, Yuval Naot, Michael A. Nardi, Philippe Brulet
The Journal of Experimental Zoology. 1999-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: